Rchr
J-GLOBAL ID:201801006546455897   Update date: Oct. 26, 2021

Makoto Nakashima

Makoto Nakashima
Affiliation and department:
Research field  (1): Tumor biology
Papers (19):
  • Makoto Yamagishi, Miyuki Kubokawa, Yuta Kuze, Ayako Suzuki, Akari Yokomizo, Seiichiro Kobayashi, Makoto Nakashima, Junya Makiyama, Masako Iwanaga, Takahiro Fukuda, et al. Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma. Nature Communications. 2021. 12. 1
  • Kazu Okuma, Madoka Kuramitsu, Toshihiro Niwa, Tomokuni Taniguchi, Yumiko Masaki, Gohzoh Ueda, Chieko Matsumoto, Rieko Sobata, Yasuko Sagara, Hitomi Nakamura, et al. Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan. Retrovirology. 2020. 17. 1. 26-26
  • Masumichi Saito, Hiroo Hasegawa, Shunsuke Yamauchi, So Nakagawa, Daisuke Sasaki, Naganori Nao, Michikazu Tanio, Yusaku Wada, Takahiro Matsudaira, Haruka Momose, et al. A high-throughput detection method for the clonality of Human T-cell leukemia virus type-1-infected cells in vivo. International journal of hematology. 2020. 112. 3. 300-306
  • Emi Ikebe, Sahoko Matsuoka, Kenta Tezuka, Madoka Kuramitsu, Kazu Okuma, Makoto Nakashima, Seiichiro Kobayashi, Junya Makiyama, Makoto Yamagishi, Seiichi Oyadomari, et al. Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1-infected cells. Blood Advances. 2020. 4. 9. 1845-1858
  • Makoto Yamagishi, Makoto Hori, Dai Fujikawa, Takeo Ohsugi, Daisuke Honma, Nobuaki Adachi, Harutaka Katano, Tsunekazu Hishima, Seiichiro Kobayashi, Kazumi Nakano, et al. Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas. Cell reports. 2019. 29. 8. 2321-2337
more...
MISC (4):
  • Yamagishi M, Kobayashi S, Makiyama J, Araya N, Nakashima M, Iwanaga M, Utsunomiya A, Tanaka Y, Watanabe T, Yamano Y, et al. Transcriptomic and epigenomic characteristics of HTLV-1 infected cells in asymptomatic carriers, HAM/TSP, and ATLL. The 19th International conference on Human Retrovirology. 2019. 45-45
  • 牧山 純也, 小林 誠一郎, 渡辺 恵理, 石垣 知寛, 川俣 豊隆, 中島 誠, 山岸 誠, 中野 和民, 東條 有伸, 渡邉 俊樹, et al. CD4+CADM1+細胞集団の割合はHTLV-1キャリアおよびインドレントATLの予後を予測する(Proportion of CD4+CADM1+ population predicts disease progression in HTLV-1 AC and indolent ATL). 臨床血液. 2018. 59. 9. 1597-1597
  • Makoto Yamagishi, Dai Fujikawa, Daisuke Honma, Nobuaki Adachi, Shota Nakagawa, Makoto Hori, Naoya Kurokawa, Ai Soejima, Kazumi Nakano, Tadanori Yamochi, et al. Polycomb-Dependent Epigenetic Landscape in Adult T Cell Leukemia (ATL); Providing Proof of Concept for Targeting EZH1/2 to Selectively Eliminate the HTLV-1 Infected Population. BLOOD. 2015. 126. 23
  • Tomiteru Togano, Makoto Nakashima, Mariko Watanabe, Kazuo Umezawa, Toshiki Watanabe, Masaaki Higashihara, Ryouichi Horie. Inhibition of NF-kappa B Activation Augments the Effect of 5-Azacytidine On Acute Myeloid Leukemia Cell Line. BLOOD. 2012. 120. 21
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page